Your browser doesn't support javascript.
loading
A wide scan of plasma proteins demonstrates thioredoxin reductase 1 as a potential new diagnostic biomarker for hepatocellular carcinoma.
Zenlander, Robin; Fredolini, Claudia; Schwenk, Jochen M; Rydén, Ingvar; Påhlsson, Peter; Löwbeer, Christian; Eggertsen, Gösta; Stål, Per.
  • Zenlander R; Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
  • Fredolini C; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Schwenk JM; Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Rydén I; Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.
  • Påhlsson P; Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.
  • Löwbeer C; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Eggertsen G; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Stål P; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Scand J Gastroenterol ; 58(9): 998-1008, 2023.
Article en En | MEDLINE | ID: mdl-37017178
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Tiorredoxina Reductasa 1 / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Tiorredoxina Reductasa 1 / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article